StemCell Institute Inc.
Research StemCell Institute Inc. (7096.T) on Bullrun: market cap JPY 7.28B, P/E 49.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7096.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyJPY
- Market capJPY 7.28B
- P/E49.1
- Financial periodFY2026
- RevenueJPY 2.81B
- Revenue growth4.9%
- Net incomeJPY 155.92M
- Free cash flow-JPY 453.32M
- Gross margin60.9%
Valuation Snapshot
latest market cap is JPY 7.28B; P/E is 49.1.
Peer valuation comparison
Latest P/E is 49.12x versus a Healthcare sector median of 21.8x (125.4% above).
Latest P/E is 49.12x versus a Japan median of 14.28x (244.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 2.81B | JPY 155.92M | -JPY 453.32M | 60.9% | 15.44 | JPY 2.83B | JPY 473.81M | JPY 2.68B |
| FY2025 | JPY 2.68B | JPY 385.80M | -JPY 107.06M | 63.2% | 37.67 | JPY 3.20B | JPY 518.96M | JPY 2.63B |
| FY2024 | JPY 2.48B | JPY 310.98M | JPY 132.97M | 63.5% | 30.35 | JPY 2.85B | JPY 8.78M | JPY 2.69B |
| FY2023 | JPY 2.09B | JPY 198.03M | JPY 39.77M | 63.9% | 19.33 | JPY 3.32B | JPY 5.89M | JPY 2.30B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 7.28B | 49.1 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
| Year | Dividends/share |
|---|---|
| FY2024 | 25 JPY |
About StemCell Institute Inc.
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is involved in Cell management and transportation services; extraction, purification, processing, storage, testing, and sale of components derived from biological tissues; research, and development, and dissemination of cell-based therapies. Its also offers the manufacturing, wholesale distribution, and sale of pharmaceuticals and medical devices.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is StemCell Institute Inc.'s market cap?
StemCell Institute Inc.'s market capitalization is JPY 7.28B.
What is StemCell Institute Inc.'s P/E ratio?
StemCell Institute Inc.'s price-to-earnings (P/E) ratio is 49.1.
What does StemCell Institute Inc. do?
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is involved in Cell management and transportation services; extraction, purification, processing, storage, testing, and sale of components derived from biological tissues; research, and development, and dissemination of cell-based therapies. Its also offers the manufacturing, wholesale distribution, and sale of pharmaceuticals and medical devices.